866-997-4948(US-Canada Toll Free)

Global Tardive Dyskinesia (TD) Therapy Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Oct 2018

Category :

Pharmaceutical

No. of Pages : 117 Pages

Tardive dyskinesia (TD) is a neurological disorder that has the involvement of the involuntary movements. The terms can be described as tardive which means delayed and dyskinesia which means abnormal movement. The symptoms of tardive dyskinesia include finger movement, facial grimacing, jaw swinging, repetitive chewing, continuous blinking of the eyes, tongue thrusting, and others.
In 2017, the global Tardive Dyskinesia (TD) Therapy market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Tardive Dyskinesia (TD) Therapy market based on company, product type, application and key regions.

This report studies the global market size of Tardive Dyskinesia (TD) Therapy in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Tardive Dyskinesia (TD) Therapy in these regions.
This research report categorizes the global Tardive Dyskinesia (TD) Therapy market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

The various contributors involved in the value chain of Tardive Dyskinesia (TD) Therapy include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Tardive Dyskinesia (TD) Therapy include
Teva Pharma
Biogen
Johnson & Johnson
GlaxoSmithKline
Neurocrine Biosciences
Pfizer
Novartis
Sanofi
AstraZeneca
Bayer AG

Market Size Split by Type
Valbenazine
Amantadine
Tetrabenazine
Clonazepam
Others
Market Size Split by Application
Hospitals
Clinics
Others

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Tardive Dyskinesia (TD) Therapy market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Tardive Dyskinesia (TD) Therapy market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Tardive Dyskinesia (TD) Therapy manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Tardive Dyskinesia (TD) Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Tardive Dyskinesia (TD) Therapy submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Tardive Dyskinesia (TD) Therapy are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Tardive Dyskinesia (TD) Therapy market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Tardive Dyskinesia (TD) Therapy Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Tardive Dyskinesia (TD) Therapy Market Size Growth Rate by Type
1.4.2 Valbenazine
1.4.3 Amantadine
1.4.4 Tetrabenazine
1.4.5 Clonazepam
1.4.6 Others
1.5 Market by Application
1.5.1 Global Tardive Dyskinesia (TD) Therapy Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Tardive Dyskinesia (TD) Therapy Market Size
2.1.1 Global Tardive Dyskinesia (TD) Therapy Revenue 2016-2025
2.1.2 Global Tardive Dyskinesia (TD) Therapy Sales 2016-2025
2.2 Tardive Dyskinesia (TD) Therapy Growth Rate by Regions
2.2.1 Global Tardive Dyskinesia (TD) Therapy Sales by Regions
2.2.2 Global Tardive Dyskinesia (TD) Therapy Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Tardive Dyskinesia (TD) Therapy Sales by Manufacturers
3.1.1 Tardive Dyskinesia (TD) Therapy Sales by Manufacturers
3.1.2 Tardive Dyskinesia (TD) Therapy Sales Market Share by Manufacturers
3.1.3 Global Tardive Dyskinesia (TD) Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Tardive Dyskinesia (TD) Therapy Revenue by Manufacturers
3.2.1 Tardive Dyskinesia (TD) Therapy Revenue by Manufacturers (2016-2018)
3.2.2 Tardive Dyskinesia (TD) Therapy Revenue Share by Manufacturers (2016-2018)
3.3 Tardive Dyskinesia (TD) Therapy Price by Manufacturers
3.4 Tardive Dyskinesia (TD) Therapy Manufacturing Base Distribution, Product Types
3.4.1 Tardive Dyskinesia (TD) Therapy Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tardive Dyskinesia (TD) Therapy Product Category
3.4.3 Date of International Manufacturers Enter into Tardive Dyskinesia (TD) Therapy Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Tardive Dyskinesia (TD) Therapy Sales by Type
4.2 Global Tardive Dyskinesia (TD) Therapy Revenue by Type
4.3 Tardive Dyskinesia (TD) Therapy Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Tardive Dyskinesia (TD) Therapy Breakdown Data by Application

6 North America
6.1 North America Tardive Dyskinesia (TD) Therapy by Countries
6.1.1 North America Tardive Dyskinesia (TD) Therapy Sales by Countries
6.1.2 North America Tardive Dyskinesia (TD) Therapy Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Tardive Dyskinesia (TD) Therapy by Type
6.3 North America Tardive Dyskinesia (TD) Therapy by Application
6.4 North America Tardive Dyskinesia (TD) Therapy by Company

7 Europe
7.1 Europe Tardive Dyskinesia (TD) Therapy by Countries
7.1.1 Europe Tardive Dyskinesia (TD) Therapy Sales by Countries
7.1.2 Europe Tardive Dyskinesia (TD) Therapy Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Tardive Dyskinesia (TD) Therapy by Type
7.3 Europe Tardive Dyskinesia (TD) Therapy by Application
7.4 Europe Tardive Dyskinesia (TD) Therapy by Company

8 Asia Pacific
8.1 Asia Pacific Tardive Dyskinesia (TD) Therapy by Countries
8.1.1 Asia Pacific Tardive Dyskinesia (TD) Therapy Sales by Countries
8.1.2 Asia Pacific Tardive Dyskinesia (TD) Therapy Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Tardive Dyskinesia (TD) Therapy by Type
8.3 Asia Pacific Tardive Dyskinesia (TD) Therapy by Application
8.4 Asia Pacific Tardive Dyskinesia (TD) Therapy by Company

9 Central & South America
9.1 Central & South America Tardive Dyskinesia (TD) Therapy by Countries
9.1.1 Central & South America Tardive Dyskinesia (TD) Therapy Sales by Countries
9.1.2 Central & South America Tardive Dyskinesia (TD) Therapy Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Tardive Dyskinesia (TD) Therapy by Type
9.3 Central & South America Tardive Dyskinesia (TD) Therapy by Application
9.4 Central & South America Tardive Dyskinesia (TD) Therapy by Company

10 Middle East and Africa
10.1 Middle East and Africa Tardive Dyskinesia (TD) Therapy by Countries
10.1.1 Middle East and Africa Tardive Dyskinesia (TD) Therapy Sales by Countries
10.1.2 Middle East and Africa Tardive Dyskinesia (TD) Therapy Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Tardive Dyskinesia (TD) Therapy by Type
10.3 Middle East and Africa Tardive Dyskinesia (TD) Therapy by Application
10.4 Middle East and Africa Tardive Dyskinesia (TD) Therapy by Company

11 Company Profiles
11.1 Teva Pharma
11.1.1 Teva Pharma Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Tardive Dyskinesia (TD) Therapy
11.1.4 Tardive Dyskinesia (TD) Therapy Product Description
11.1.5 Recent Development
11.2 Biogen
11.2.1 Biogen Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Tardive Dyskinesia (TD) Therapy
11.2.4 Tardive Dyskinesia (TD) Therapy Product Description
11.2.5 Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Tardive Dyskinesia (TD) Therapy
11.3.4 Tardive Dyskinesia (TD) Therapy Product Description
11.3.5 Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Tardive Dyskinesia (TD) Therapy
11.4.4 Tardive Dyskinesia (TD) Therapy Product Description
11.4.5 Recent Development
11.5 Neurocrine Biosciences
11.5.1 Neurocrine Biosciences Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Tardive Dyskinesia (TD) Therapy
11.5.4 Tardive Dyskinesia (TD) Therapy Product Description
11.5.5 Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Tardive Dyskinesia (TD) Therapy
11.6.4 Tardive Dyskinesia (TD) Therapy Product Description
11.6.5 Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Tardive Dyskinesia (TD) Therapy
11.7.4 Tardive Dyskinesia (TD) Therapy Product Description
11.7.5 Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Tardive Dyskinesia (TD) Therapy
11.8.4 Tardive Dyskinesia (TD) Therapy Product Description
11.8.5 Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Tardive Dyskinesia (TD) Therapy
11.9.4 Tardive Dyskinesia (TD) Therapy Product Description
11.9.5 Recent Development
11.10 Bayer AG
11.10.1 Bayer AG Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Tardive Dyskinesia (TD) Therapy
11.10.4 Tardive Dyskinesia (TD) Therapy Product Description
11.10.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Tardive Dyskinesia (TD) Therapy Raw Material
13.1.2 Tardive Dyskinesia (TD) Therapy Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Tardive Dyskinesia (TD) Therapy
Figure Global Tardive Dyskinesia (TD) Therapy Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Tardive Dyskinesia (TD) Therapy Production Market Share by Types (Product Category) in 2017
Figure Valbenazine Product Picture
Table Major Manufacturers of Valbenazine
Figure Amantadine Product Picture
Table Major Manufacturers of Amantadine
Figure Tetrabenazine Product Picture
Table Major Manufacturers of Tetrabenazine
Figure Clonazepam Product Picture
Table Major Manufacturers of Clonazepam
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Tardive Dyskinesia (TD) Therapy Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Hospitals
Figure Clinics
Figure Others
Figure Tardive Dyskinesia (TD) Therapy Report Years Considered
Figure Global Tardive Dyskinesia (TD) Therapy Market Size 2016-2025 (Million US$)
Figure Global Tardive Dyskinesia (TD) Therapy Sales 2016-2025 (K Units)
Table Global Tardive Dyskinesia (TD) Therapy Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Tardive Dyskinesia (TD) Therapy Sales by Regions 2016-2025 (K Units)
Table Global Tardive Dyskinesia (TD) Therapy Sales Market Share by Regions 2016-2025
Figure Global Tardive Dyskinesia (TD) Therapy Sales Market Share by Regions 2016-2025
Figure 2017 Global Tardive Dyskinesia (TD) Therapy Sales Market Share by Regions
Table Global Tardive Dyskinesia (TD) Therapy Revenue by Regions 2016-2025 (Million US$)
Table Global Tardive Dyskinesia (TD) Therapy Revenue Market Share by Regions 2016-2025
Figure Global Tardive Dyskinesia (TD) Therapy Revenue Market Share by Regions 2016-2025
Figure 2017 Global Tardive Dyskinesia (TD) Therapy Revenue Market Share by Regions
Table Global Tardive Dyskinesia (TD) Therapy Sales by Manufacturers (2016-2018) (K Units)
Table Global Tardive Dyskinesia (TD) Therapy Sales Share by Manufacturers (2016-2018)
Figure Global Tardive Dyskinesia (TD) Therapy Sales Share by Manufacturers in 2017
Table Tardive Dyskinesia (TD) Therapy Revenue by Manufacturers (2016-2018) (Million US$)
Table Tardive Dyskinesia (TD) Therapy Revenue Share by Manufacturers (2016-2018)
Figure Tardive Dyskinesia (TD) Therapy Value Share by Manufacturers in 2017
Table Global Tardive Dyskinesia (TD) Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Tardive Dyskinesia (TD) Therapy Price (2016-2018) (USD/Unit)
Table Tardive Dyskinesia (TD) Therapy Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Tardive Dyskinesia (TD) Therapy Product Category
Table Date of International Manufacturers Enter into Tardive Dyskinesia (TD) Therapy Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Tardive Dyskinesia (TD) Therapy Sales by Type (2016-2025) (K Units)
Table Global Tardive Dyskinesia (TD) Therapy Sales Share by Type (2016-2025)
Figure Global Tardive Dyskinesia (TD) Therapy Sales Market Share by Type (2016-2025)
Figure Global Tardive Dyskinesia (TD) Therapy Sales Market Share by Type in 2017
Table Global Tardive Dyskinesia (TD) Therapy Revenue by Type (2016-2025) (Million US$)
Table Global Tardive Dyskinesia (TD) Therapy Revenue Share by Type (2016-2025)
Figure Global Tardive Dyskinesia (TD) Therapy Revenue Market Share by Type (2016-2025)
Figure Global Tardive Dyskinesia (TD) Therapy Revenue Market Share by Type in 2017
Table Tardive Dyskinesia (TD) Therapy Price by Type 2013-2018 (USD/Unit)
Table Global Tardive Dyskinesia (TD) Therapy Sales by Application (2016-2025) (K Units)
Table Global Tardive Dyskinesia (TD) Therapy Sales Share by Application (2016-2025)
Figure Global Sales Tardive Dyskinesia (TD) Therapy Market Share by Application (2016-2025)
Figure Global Sales Tardive Dyskinesia (TD) Therapy Market Share by Application (2016-2025)
Figure North America Tardive Dyskinesia (TD) Therapy Sales Growth Rate 2016-2025 (K Units)
Figure North America Tardive Dyskinesia (TD) Therapy Revenue Growth Rate 2016-2025 (Million US$)
Table North America Tardive Dyskinesia (TD) Therapy Sales by Countries (2016-2025) (K Units)
Table North America Tardive Dyskinesia (TD) Therapy Sales Market Share by Countries (2016-2025)
Figure 2017 North America Tardive Dyskinesia (TD) Therapy Sales Market Share by Countries
Table North America Tardive Dyskinesia (TD) Therapy Revenue by Countries (2016-2025) (Million US$)
Table North America Tardive Dyskinesia (TD) Therapy Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Tardive Dyskinesia (TD) Therapy Revenue Market Share by Countries
Figure United States Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2016-2025) (K Units)
Figure United States Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Canada Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2016-2025) (Million US$)
Table North America Tardive Dyskinesia (TD) Therapy Sales by Type (2016-2025) (K Units)
Table North America Tardive Dyskinesia (TD) Therapy Sales Market Share by Type (2016-2025)
Figure 2017 North America Tardive Dyskinesia (TD) Therapy Market Share by Type
Table North America Tardive Dyskinesia (TD) Therapy Sales by Application (2016-2025) (K Units)
Table North America Tardive Dyskinesia (TD) Therapy Sales Market Share by Application (2016-2025)
Figure 2017 North America Tardive Dyskinesia (TD) Therapy Market Share by Application
Table North America Tardive Dyskinesia (TD) Therapy Sales by Company (2016-2018) (K Units)
Table North America Tardive Dyskinesia (TD) Therapy Sales Market Share by Company (2016-2018)
Figure North America Tardive Dyskinesia (TD) Therapy Sales Market Share by Company in 2017
Figure Europe Tardive Dyskinesia (TD) Therapy Sales Growth Rate 2016-2025 (K Units)
Figure Europe Tardive Dyskinesia (TD) Therapy Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Tardive Dyskinesia (TD) Therapy Sales by Countries (2016-2025) (K Units)
Table Europe Tardive Dyskinesia (TD) Therapy Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Tardive Dyskinesia (TD) Therapy Sales Market Share by Countries
Table Europe Tardive Dyskinesia (TD) Therapy Revenue by Countries (2016-2025) (Million US$)
Table Europe Tardive Dyskinesia (TD) Therapy Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Tardive Dyskinesia (TD) Therapy Revenue Market Share by Countries
Figure Germany Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Germany Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2016-2025) (K Units)
Figure France Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2016-2025) (K Units)
Figure France Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2016-2025) (K Units)
Figure UK Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2016-2025) (K Units)
Figure UK Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Italy Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Russia Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Tardive Dyskinesia (TD) Therapy Sales by Type (2016-2025) (K Units)
Table Europe Tardive Dyskinesia (TD) Therapy Sales Market Share by Type (2016-2025)
Figure 2017 Europe Tardive Dyskinesia (TD) Therapy Market Share by Type
Table Europe Tardive Dyskinesia (TD) Therapy Sales by Application (2016-2025) (K Units)
Table Europe Tardive Dyskinesia (TD) Therapy Sales Market Share by Application (2016-2025)
Figure 2017 Europe Tardive Dyskinesia (TD) Therapy Market Share by Application
Table Europe Tardive Dyskinesia (TD) Therapy Sales by Company (2016-2018) (K Units)
Table Europe Tardive Dyskinesia (TD) Therapy Sales Market Share by Company (2016-2018)
Figure Europe Tardive Dyskinesia (TD) Therapy Sales Market Share by Company in 2017
Figure Asia Pacific Tardive Dyskinesia (TD) Therapy Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Tardive Dyskinesia (TD) Therapy Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Tardive Dyskinesia (TD) Therapy Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Tardive Dyskinesia (TD) Therapy Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Tardive Dyskinesia (TD) Therapy Sales Market Share by Countries
Table Asia Pacific Tardive Dyskinesia (TD) Therapy Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Tardive Dyskinesia (TD) Therapy Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Tardive Dyskinesia (TD) Therapy Revenue Market Share by Countries
Figure China Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2016-2025) (K Units)
Figure China Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Japan Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Korea Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure India Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2016-2025) (K Units)
Figure India Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Australia Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Tardive Dyskinesia (TD) Therapy Sales by Type (2016-2025) (K Units)
Table Asia Pacific Tardive Dyskinesia (TD) Therapy Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Tardive Dyskinesia (TD) Therapy Market Share by Type
Table Asia Pacific Tardive Dyskinesia (TD) Therapy Sales by Application (2016-2025) (K Units)
Table Asia Pacific Tardive Dyskinesia (TD) Therapy Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Tardive Dyskinesia (TD) Therapy Market Share by Application
Table Asia Pacific Tardive Dyskinesia (TD) Therapy Sales by Company (2016-2018) (K Units)
Table Asia Pacific Tardive Dyskinesia (TD) Therapy Sales Market Share by Company (2016-2018)
Figure Asia Pacific Tardive Dyskinesia (TD) Therapy Sales Market Share by Company in 2017
Figure Central & South America Tardive Dyskinesia (TD) Therapy Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Tardive Dyskinesia (TD) Therapy Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Tardive Dyskinesia (TD) Therapy Sales by Countries (2016-2025) (K Units)
Table Central & South America Tardive Dyskinesia (TD) Therapy Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Tardive Dyskinesia (TD) Therapy Sales Market Share by Countries
Table Central & South America Tardive Dyskinesia (TD) Therapy Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Tardive Dyskinesia (TD) Therapy Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Tardive Dyskinesia (TD) Therapy Revenue Market Share by Countries
Figure Brazil Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Tardive Dyskinesia (TD) Therapy Sales by Type (2016-2025) (K Units)
Table Central & South America Tardive Dyskinesia (TD) Therapy Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Tardive Dyskinesia (TD) Therapy Market Share by Type
Table Central & South America Tardive Dyskinesia (TD) Therapy Sales by Application (2016-2025) (K Units)
Table Central & South America Tardive Dyskinesia (TD) Therapy Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Tardive Dyskinesia (TD) Therapy Market Share by Application
Table Central & South America Tardive Dyskinesia (TD) Therapy Sales by Company (2016-2018) (K Units)
Table Central & South America Tardive Dyskinesia (TD) Therapy Sales Market Share by Company (2016-2018)
Figure Central & South America Tardive Dyskinesia (TD) Therapy Sales Market Share by Company in 2017
Figure Middle East and Africa Tardive Dyskinesia (TD) Therapy Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Tardive Dyskinesia (TD) Therapy Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Tardive Dyskinesia (TD) Therapy Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Tardive Dyskinesia (TD) Therapy Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Tardive Dyskinesia (TD) Therapy Sales Market Share by Countries
Table Middle East and Africa Tardive Dyskinesia (TD) Therapy Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Tardive Dyskinesia (TD) Therapy Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Tardive Dyskinesia (TD) Therapy Revenue Market Share by Countries
Figure GCC Countries Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Tardive Dyskinesia (TD) Therapy Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Tardive Dyskinesia (TD) Therapy Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Tardive Dyskinesia (TD) Therapy Market Share by Type
Table Middle East and Africa Tardive Dyskinesia (TD) Therapy Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Tardive Dyskinesia (TD) Therapy Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Tardive Dyskinesia (TD) Therapy Market Share by Application
Table Middle East and Africa Tardive Dyskinesia (TD) Therapy Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Tardive Dyskinesia (TD) Therapy Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Tardive Dyskinesia (TD) Therapy Sales Market Share by Company in 2017
Table Teva Pharma Company Details
Table Teva Pharma Tardive Dyskinesia (TD) Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Teva Pharma Recent Development
Table Biogen Company Details
Table Biogen Tardive Dyskinesia (TD) Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Biogen Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Tardive Dyskinesia (TD) Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Johnson & Johnson Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Tardive Dyskinesia (TD) Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table GlaxoSmithKline Recent Development
Table Neurocrine Biosciences Company Details
Table Neurocrine Biosciences Tardive Dyskinesia (TD) Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Neurocrine Biosciences Recent Development
Table Pfizer Company Details
Table Pfizer Tardive Dyskinesia (TD) Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis Tardive Dyskinesia (TD) Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Novartis Recent Development
Table Sanofi Company Details
Table Sanofi Tardive Dyskinesia (TD) Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sanofi Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Tardive Dyskinesia (TD) Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table AstraZeneca Recent Development
Table Bayer AG Company Details
Table Bayer AG Tardive Dyskinesia (TD) Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Bayer AG Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Tardive Dyskinesia (TD) Therapy Value Chain
Table Typical Suppliers of Key Tardive Dyskinesia (TD) Therapy Raw Material
Table Tardive Dyskinesia (TD) Therapy Customers List
Table Tardive Dyskinesia (TD) Therapy Sales Channels
Table Tardive Dyskinesia (TD) Therapy Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *